Volume 5 • Issue 2 : Special Issue CITCOVID-19 • PP: PP. 21-22 • 2021
A Novel Artificial Face Mask based Nanofibers with Special Intelligent Engineered Nanocomposite Against Covid-19
Open Access & Copyright
© 2021 The Author(s). Published by ASPG. This article is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Abstract
We introduce our idea about a new face mask against Covid-19. Herein our novel face mask is a polymeric matrix of nanofibers. These nanofibers are decorated with special engineered nanocomposite. The later possesses antiviral, antimicrobial. Awell-established IR temperature biosensor will be implanted in the face mask and connected to the mobile phone using App (Seek thermal) to allow temperature monitoring. Artificial Intelligence can play a vital role in the fight against COVID-19. AI is being successfully used in the identification of disease clusters, monitoring of cases, prediction of the future outbreaks, mortality risk, diagnosis of COVID-19, disease management by resource allocation, facilitating training, record maintenance and pattern recognition for studying the disease trend. Therefore, AI is used as a type of alarm which be connected through Global Position System (GPS) to a central networking system to monitor the crowded areas of probable infections. In this case, the hospital in this neighborhood will be charged to let a mobile unit of assessment travel quickly to the infected people areas.
Keywords
References
[1] O’Dowd, K.; Nair, K.M.; Forouzandeh, P.; Mathew, S.; Grant, J.; Moran, R.; Bartlett, J.; Bird, J.; Pillai, S.C. Face masks and respirators in the fight against the COVID-19 pandemic: A review of current materials, advances and future perspectives. Materials 2020, 13, 3363.
[2] Chua, M.H.; Cheng, W.; Goh, S.S.; Kong, J.; Li, B.; Lim, J.Y.C.; Mao, L.; Wang, S.; Xue, K.; Yang, L.; et al. Face Masks in the New COVID-19 Normal: Materials, Testing, and Perspectives. Research 2020, 2020, 7286735.
[3] Randhawa GS, Soltysiak MP, El Roz H et al. Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study. PLoS ONE 15(4), e0232391 (2020).
[4] Abdulla A, Wang B, Qian F et al. Project IDentif. AI: harnessing artificial intelligence to rapidly optimize combination therapy development for infectious disease intervention. Adv. Ther. 3(7), 2000034 (2020).
Cite This Article
Choose your preferred format
Publisher's Note
The statements, opinions, and data presented in this article are solely those of the author(s) and do not necessarily represent those of ASPG, the journal, or its editors. ASPG and the editors disclaim responsibility for any harm arising from the use of any ideas, methods, instructions, or products described in this article, to the fullest extent permitted by applicable law.